Huberman Lab
Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity
Andrew Huberman
I definitely want to circle back as to what the motivation was by the FDA for doing that at some point. I think in the meantime, however, I think there's a lot of interest in BPC-157, a lot of use of BPC-157. The sources of BPC-157 are now drying up. And That's why I'm personally concerned that people are going to start going to the dark gray market and black market.
0
💬
0
Comments
Log in to comment.
There are no comments yet.